Claire Nowak

Articles by Claire Nowak

Claire NowakUncategorized | December 4, 2024
cookie test
Claire NowakMyeloma | September 13, 2024
The bispecific antibody was administered as a fourth-line treatment 12 years after the patient’s diagnosis.
Claire NowakMyeloma | September 13, 2024
Prior to the retrospective study presented at SOHO 2024, no study conducted a similar comparison of Dara-VTD and RVD.
Claire NowakMyeloma | September 13, 2024
Prior research suggested that weekly carfilzomib at a dose of 70 mg/m2 plus dexamethasone can increase PFS.
Claire NowakMyeloma | September 20, 2024
The phase III KarMMa-9 trial will review the efficacy of R maintenance alone versus with ide-cel in newly diagnosed MM.
Featuring a review of third-line therapy options for CML, meeting news from the 2022 ESMO Congress, and more
A debate on whether MRD negativity indicates a cure in patients with ALL, and more
How chemotherapy-free regimens are more commonly being used for treatment, and more
Updates on COVID-19 and hematologic malignancies, and more
New goals from the Cancer Moonshot 2.0 study, and more
Evidence from recent CAR T-cell therapy clinical trials, and more